Maine Statutes
§ 22 §1711-E — Confidentiality of prescription drug information
1.Definitions.
As used in this section, unless the context otherwise indicates, the following terms have the following meanings.
1-A.
Findings.
1-B.
Purposes.
2.Confidentiality of prescription drug information that identifies the individual.
A carrier or prescription drug information intermediary may not license, use, sell, transfer or exchange for value, for any marketing purpose, prescription drug information that identifies directly or indirectly the individual who is prescribed the prescription drug.
2-A.
Confidentiality of prescription drug information that identifies the prescriber.
3.Enforcement.
A violation of subsection 2 is a violation of the Maine Unfair Trade Practices Act.
4.Confidentiality protection procedures.
5.Rules.
The department shall adopt rules to implement this
Free access — add to your briefcase to read the full text and ask questions with AI
Maine § 22 §1711-E (Confidentiality of prescription drug information) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
PL 2005, c. 589, §1 (NEW). PL 2007, c. 460, §1 (AMD). PL 2007, c. 695, Pt. C, §§6, 7 (AMD). PL 2011, c. 90, Pt. J, §10 (AMD). PL 2011, c. 443, §1 (AMD). PL 2011, c. 461, §1 (AMD). PL 2011, c. 494, §§1-6 (AMD). PL 2019, c. 469, §1 (AMD). PL 2019, c. 469, §9 (AFF).
Nearby Sections
8
§ 22 §1711-A
Fees charged for records§ 22 §1711-C
Confidentiality of health care information§ 22 §1711-D
Designation of visitors in hospital settings§ 22 §1711-E
Confidentiality of prescription drug information§ 22 §1711-F
Transfer of member health care information by MaineCare program for purpose of diagnosis, treatment or care§ 22 §1711-G
Designated lay caregivers